LuciCapiva

About this medicine

Originator: TRUQAP by ASTRAZENECA · Manufacturer: Lucius Pharma. Indication & Dosage: LuciCapiva (Capivasertib), generic TRUQAP is a prescription medicine used to treat treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer harboring one or more PIK3CA, AKT1, or PTEN alterations. This indication applies to patients who have experienced disease progression on at least one endocrine-based therapy in the metastatic setting or recurrence within 12 months of completing adjuvant therapy. LuciCapiva manufactured by Lucius Pharma Ltd. in Laos. Capivasertib has to take orally twice daily with or without food. Side Effects: The most common side effects of Capivasertib are: Diarrhea, Nausea, Vomiting, Fatigue, Decreased appetite, Rash, Increased blood glucose levels, Decreased lymphocyte counts. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.